Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 107, Issue 1, Pages 46-52
Publisher
Springer Nature
Online
2011-11-15
DOI
10.1038/ajg.2011.384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies
- (2010) Hung-Da Tung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
- (2010) E. K. K. Lam et al. ANNALS OF ONCOLOGY
- Inability of waist-to-height ratio to predict new onset diabetes mellitus among older adults in Taiwan: A five-year observational cohort study
- (2010) Ren-Jieh Kuo et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
- (2010) M. Pollak Cancer Prevention Research
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor γ-independent regulation of nucleophosmin
- (2010) Andrea Galli et al. HEPATOLOGY
- Substantially increased risk of cancer in patients with diabetes mellitus
- (2010) Hiroshi Noto et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Non-viral causes of hepatocellular carcinoma
- (2010) Wojciech Blonski WORLD JOURNAL OF GASTROENTEROLOGY
- The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses
- (2009) C.-S. Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
- (2009) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnosis and Treatment of Hepatocellular Carcinoma
- (2008) Hashem B. El-Serag et al. GASTROENTEROLOGY
- Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus
- (2008) Bart J. Veldt et al. HEPATOLOGY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now